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Shigella ﬂexneri is an infectious pathogen that causes dysentery to human, which
remains a serious threat to public health, particularly in developing countries. In
this study, the global protein expression patterns of S. ﬂexneri during transition
from exponential growth to stationary phase in vitro were analyzed by using 2-D
PAGE combined with MALDI-TOF MS. In a time-course experiment with five
time points, the relative abundance of 49 protein spots varied signif icantly. In-
terestingly, a putative outer membrane protein YciD (OmpW) was almost not
detected in the exponential growth phase but became one of the most abundant
proteins in the whole stationary-phase proteome. Some proteins regulated by the
global regulator FNR were also signif icantly induced (such as AnsB, AspA, FrdAB,
and KatG) or repressed (such as AceEF, OmpX, SodA, and SucAB) during the
growth phase transition. These proteins may be the key effectors of the bacterial
cell cycle or play important roles in the cellular maintenance and stress responses.
Our expression profile data provide valuable information for the study of bacterial
physiology and form the basis for future proteomic analyses of this pathogen.
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Introduction
Shigella species is a group of Gram-negative, non-
spore forming, facultative pathogens closely related to
Escherichia coli. The bacteria cause a disease called
shigellosis in humans, an infection of the large in-
testine characterized by abdominal cramps, diarrhea,
and fever. They can enter epithelial cells and trigger
apoptosis in macrophages. There are four different
species of Shigella based on the differences in O anti-
gen and some biochemical reactions (1 ). Among
them, Shigella ﬂexneri is responsible for the majority
of cases of endemic dysentery prevalent in developing
countries where sanitation is poor. Most affected by
this organism are children under five years old (2 ).
Owing to the low infectious dose (10 to 100 bacte-
ria) and the emergence of multiple resistance strains,
knowledge about the physiology and pathogenesis of




The traditional bacterial life cycle has three
phases, including lag phase, exponential or logarith-
mic phase, and stationary phase, while it can be ex-
panded to include two additional phases: death phase
and long-term stationary phase (3 ). The exponen-
tial phase is characterized by a period of popula-
tion doublings, in which the cells consume nutrients
and excrete waste products. The stationary phase is
initiated as nutrient or toxic product concentrations
reaching levels that can no longer support the max-
imum rate of growth. During transition from expo-
nential growth to stationary phase, bacteria experi-
ence various environmental changes and their repro-
ductive ability is gradually lost. However, the molec-
ular mechanism underlying this trade-off between re-
production and survival has not been fully deciphered
(4 ).
To investigate the physiology and molecular bi-
ology in a global scale during this transition, pro-
teomic approaches have been applied in previous stud-
ies (5 , 6 ). In this study, we provide the profiles
of phase-dependent proteins produced by S. ﬂexneri
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with high resolution and sensitivity. These data will
expand our understanding of the question that how
the whole proteome is regulated during the growth of
this pathogen.
Results
Growth curve of S. ﬂexneri 2a 2457T
The growth curve of S. ﬂexneri serotype 2a strain
2457T in batch culture was constructed from the val-
ues of optical density OD600nm as shown in Figure 1
(see Materials and Methods). We collected the bac-
teria and sampled for every 1 h from the exponential
phase at OD600nm of 0.6. The values of OD600nm and
the viability counts at each time point were measured
(Table 1).
Protein expression profiles of S.
ﬂexneri 2a 2457T at different stages
Previous proteomic research of S. ﬂexneri showed
that most protein spots were scattered in the pI re-
gions of pH 4–7 (7 ). Thus, our research also focused
on the changes of acidic proteins at different stages.
As shown in Figure 2, the five two-dimensional
polyacrylamide gel electrophoresis (2-D PAGE) gels
of different stages are comparable with each other.
More than 1,000 spots were detected on all of the five
gels by Colloidal CBB staining. The total number of
protein spots increased from Stages I to III, and then
decreased from Stages IV to V. Some phase-specific
proteins were almost not detected in Stage I or V.
Most of the proteins whose expressions were contin-
ually induced or repressed and some of the proteins
whose expressions fluctuated at different stages were
cut out for further analysis. These protein spots are
also indicated in Figure 2.
Identification and analysis of selected
proteins
After destaining and in-gel trypsin digestion, a total
of 49 spots representing 46 proteins were identified
by matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS). The
database search results about these proteins are sum-
marized in Table 2.
Fig. 1 The growth curve of S. ﬂexneri 2a 2457T in vitro at 37◦C. Arrows indicate the five time points (Stages I–V)
at which the experiments were carried out.
Table 1 The values of OD600nm and the viability counts at Stages I–V*
Stage I II III IV V
OD600nm 0.6 1.10±0.01 1.70±0.09 1.95±0.05 2.32±0.08
Viability counts (108 CFU) 1.54±0.14 2.35±0.29 5.67±0.99 12.8±1.20 16.07±1.56
*OD600nm: optical density under 600 nm wavelength. CFU: colony forming units.
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Fig. 2 Protein expression profiles of S. ﬂexneri 2a 2457T at each growth stage. A–E: Stages I–V. Proteins were
separated by IEF in the first dimension (18 cm) in the pI range of pH 4–7 and by 12.5% SDS-PAGE in the second
dimension, and were detected by Coomassie-staining. Identified proteins were indicated by arrows and spot numbers
(High-resolution graphs are available from authors upon request).
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Table 2 Identif ication of 46 proteins by MALDI-TOF MS from S. ﬂexneri 2a 2457T
produced differentially at each growth stage
Spot Protein Score Accession Locus ID Sequence No. of Protein description
No. symbol No. coverage matched
peptides
G01 YciD 69 gi|30062779 S1345 48% 10 putative outer membrane protein
G02 YfiD 129 gi|30063980 S2814 66% 11 putative formate acetyltransferase
G03 YnaF 70 gi|30062868 S1449 35% 9 putative filament protein
G04 AnsB 55 gi|30064278 S3157 29% 8 periplasmic L-asparaginase II
G05 FabI 176 gi|30062809 S1375 59% 20 enoyl-[acyl-carrier-protein] reductase (NADH)
G06 AspA 73 gi|30065514 S4560 22% 7 aspartate ammonia-lyase (aspartase)
G08 FrdB 86 gi|30065530 S4576 56% 12 fumarate reductase, iron-sulfur protein subunit
G11 MglB 66 gi|30063593 S2364 35% 9 galactose-binding transport protein
G12 PckA 58 gi|30065314 S4341 16% 6 phosphoenolpyruvate carboxykinase
G13 GlpQ 156 gi|30063673 S2454 76% 24 glycerophosphodiester phosphodiesterase
G14 RpsA 130 gi|30062446 S0971 39% 21 30S ribosomal subunit protein S1
G15 CpdB 103 gi|30065494 S4538 24% 11 2:3-cyclic-nucleotide 2-phosphodiesterase
G17 AspS 193 gi|30063276 S1942 44% 24 aspartate tRNA synthetase
G18 AlaS 59 gi|30064057 S2911 22% 12 alanyl-tRNA synthetase
G19 SodA 94 gi|30064799 S3763 58% 10 superoxide dismutase, manganese
G20 AsnS 201 gi|30062465 S0991 38% 18 asparagine tRNA synthetase
G21 GuaA 208 gi|30063899 S2725 40% 20 GMP synthetase (glutamine-hydrolyzing)
G22 YihK 150 gi|30064840 S3805 26% 14 putative GTP-binding factor
G23 Pta 223 gi|30063723 S2508 41% 25 phosphotransacetylase
G24 FusA 198 gi|30065374 S4404 52% 25 GTP-binding protein chain elongation factor EF-G
G25 AceE 246 gi|30061680 S0113 41% 30 pyruvate dehydrogenase (E1 component)
G26 SerS 98 gi|30062380 S0893 33% 13 serine tRNA synthetase
G27 Rnb 107 gi|30062807 S1373 28% 16 RNase II, mRNA degradation
G28 SucB 82 gi|30062110 S0583 24% 10 2-oxoglutarate dehydrogenase (E2 component)
G29 GltX 70 gi|30063801 S2605 24% 9 glutamate tRNA synthetase, catalytic subunit
G31 MrsA 147 gi|30064514 S3434 41% 16 putative phosphoglucomutase
G32 PykF 226 gi|30063190 S1838 59% 29 pyruvate kinase I
G33 OmpX 59 gi|30062298 S0807 35% 5 outer membrane protein X
G34 RpsF 61 gi|30065571 S4625 56% 9 30S ribosomal subunit protein S6
G35 SucA 143 gi|30062111 S0584 35% 27 2-oxoglutarate dehydrogenase (E1 component)
G36 Lon 255 gi|30061941 S0390 49% 34 DNA-binding, ATP-dependent protease La
G37 YhgF 99 gi|30065310 S4337 29% 14 hypothetical protein
G38 GlgB 91 gi|30065284 S4308 27% 17 1,4-alpha-glucan branching enzyme
G40 Prc 163 gi|30062914 S1511 39% 23 carboxy-terminal protease for penicillin-binding
protein 3
G41 GyrB 162 gi|30065007 S4006 37% 21 DNA gyrase subunit B, type II topoisomerase
G42 NuoG 135 gi|30063709 S2494 31% 19 NADH dehydrogenase I chain G
G43 PflB 183 gi|30062438 S0962 40% 26 formate acetyltransferase 1
G44 FrdA 166 gi|30065531 S4577 49% 24 fumarate reductase, anaerobic,
flavoprotein subunit
G45 CysK 192 gi|30063808 S2615 83% 24 cysteine synthase A,
O-acetylserine sulfhydrolase A
G46 RplI 143 gi|30065574 S4628 73% 13 50S ribosomal subunit protein L9
G48 DksA 109 gi|30061705 S0140 76% 13 dnaK suppressor protein
114 Geno. Prot. Bioinfo. Vol. 5 No. 2 2007
Zhu et al.
Table 2 Continued
Spot Protein Score Accession Locus ID Sequence No. of Protein description
No. symbol No. coverage matched
peptides
G49 AceF 193 gi|30061681 S0114 51% 25 pyruvate dehydrogenase (E2 component)
G50 KatG 146 gi|30064765 S3727 33% 21 catalase; hydroperoxidase HPI(I)
G51 KatG 154 gi|30064765 S3727 36% 22 catalase; hydroperoxidase HPI(I)
G52 KatG 149 gi|30064765 S3727 36% 21 catalase; hydroperoxidase HPI(I)
G53 KatG 207 gi|30064765 S3727 48% 28 catalase; hydroperoxidase HPI(I)
G54 FucO 121 gi|30064145 S3008 46% 16 L-1,2-propanediol oxidoreductase
G55 OmpA 93 gi|30062494 S1023 52% 11 outer membrane protein 3a (II*;G;d)
G56 PurC 101 gi|30063855 S2669 59% 13 phosphoribosylaminoimidazole-
succinocarboxamide synthetase,
SAICAR synthetase
Bioinformatic analyses revealed that proteins in-
volved in energy production and conversion (12/46)
and translation (9/46) comprise a major part of
the identified proteins. Others were related to cell
wall or membrane biogenesis (4/46), carbohydrate
metabolism (3/46), signal transduction (3/46), and
so on. As to the subcellular localization, more than
two thirds of these proteins were localized in cyto-
plasm. Besides, membrane proteins and periplasmic
proteins were included, but only as a minor part.
The detailed functional categories of these proteins
based on the classification of Clusters of Ortholo-
gous Groups (http://www.ncbi.nlm.nih.gov/COG/)
and the cellular localizations predicted by PSORTb
v.2.0 (www.psort.org) were listed in Table 3. The rel-
ative abundance and expression patterns of identified
proteins in the five gels at different stages were also
described.
Table 3 Expression patterns and bioinformatic analyses of identif ied proteins
Spot Protein Expression Relative abundance (volume)*2 COG*3 Localization
No. symbol pattern*1 Stage I Stage II Stage III Stage IV Stage V
G01 YciD ↑↑↑↑ ND 0.338122 1.056830 1.431120 1.951640 M Outer membrane
G02 YfiD ↑↑→↘ 0.122546 0.360338 0.506921 0.518904 0.487855 R Cytoplasm
G03 YnaF ↑↑↑↑ 0.129985 0.243320 0.378834 0.649238 0.865560 T Cytoplasm
G04 AnsB ↑↑↑↗ ND 0.191641 0.609328 0.911144 1.003750 – Periplasmic space
G05 FabI ↓↘→↘ 0.655974 0.507885 0.455764 0.437274 0.383020 I Unknown
G06 AspA ↑↗↑↗ 0.208366 0.807826 0.898268 1.145140 1.234040 E Cytoplasm
G08 FrdB ↑↑↘↑ 0.052497 0.107804 0.158431 0.143258 0.172969 C Cytoplasm
G11 MglB ↑↑↑↑ 0.045452 0.082542 0.105270 0.365603 0.521490 G Periplasmic space
G12 PckA ↑↑↑↑ 0.079557 0.140732 0.198588 0.257121 0.341101 C Cytoplasm
G13 GlpQ ↑↑↑↑ 0.088047 0.116600 0.156208 0.236151 0.372681 C Periplasmic space
G14 RpsA →↘↘↘ 1.965550 1.884280 1.632840 1.422320 1.253910 J Cytoplasm
G15 CpdB ↑↑↑↑ 0.021617 0.028734 0.041985 0.056666 0.068310 F Periplasmic space
G17 AspS ↓↑↓↓ 0.183388 0.139781 0.192009 0.038185 ND J Cytoplasm
G18 AlaS ↑↓↓↓ 0.012097 0.022594 0.013836 0.002166 ND J Cytoplasm
G19 SodA ↓↓↓↓ 0.963829 0.518527 0.320438 0.252952 0.209230 P Unknown
G20 AsnS ↑↘↘↓ 0.143868 0.230065 0.199732 0.180855 0.134321 J Cytoplasm
G21 GuaA ↑↓↗↘ 0.073454 0.155249 0.100114 0.111852 0.095319 F Cytoplasm
G22 YihK ↓→↓↘ 0.160888 0.130163 0.126678 0.053317 0.047732 T Cytoplasmic membrane
G23 Pta ↓↑↓↘ 0.220020 0.162679 0.236062 0.173103 0.158659 C, R Unknown
G24 FusA ↓↗↓↗ 1.034700 0.856892 0.930851 0.326459 0.360715 J Cytoplasm
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Table 3 Continued
Spot Protein Expression Relative abundance (volume)*2 COG*3 Localization
No. symbol pattern*1 Stage I Stage II Stage III Stage IV Stage V
G25 AceE →↓↓↓ 0.223033 0.228866 0.149161 0.024703 0.003513 C Unknown
G26 SerS ↓↘↓↓ 0.343742 0.251948 0.216105 0.093690 0.073963 J Cytoplasm
G27 Rnb ↑↓↓↓ 0.066073 0.109783 0.079980 0.042138 0.027965 – Cytoplasm
G28 SucB ↓↓↓↓ 0.802532 0.632209 0.516970 0.164995 0.100566 C Cytoplasm
G29 GltX ↓↘↓↓ 0.153128 0.103487 0.097153 0.053246 0.032579 J Cytoplasm
G31 MrsA ↓↘↓↓ 0.099794 0.063662 0.056220 0.032481 ND G Cytoplasm
G32 PykF ↓↘↓↓ 0.286286 0.234922 0.199617 0.156574 0.114607 – Unknown
G33 OmpX ↑↘↓↘ 0.048283 0.189300 0.165548 0.129116 0.120927 M Outer membrane
G34 RpsF ↓↓↓↓ 0.574083 0.303693 0.219162 0.148161 0.099665 J Cytoplasm
G35 SucA ↓↓↓ − 0.045815 0.021244 0.003809 ND ND C Cytoplasm
G36 Lon ↓↓ −− 0.038085 0.004564 ND ND ND O Cytoplasm
G37 YhgF ↑↘↓↓ 0.011495 0.021962 0.019492 0.011606 0.007427 K Cytoplasm
G38 GlgB ↑↓↓↓ 0.023470 0.036323 0.019335 0.006417 ND G Unknown
G40 Prc ↑↓↓ − 0.022055 0.032399 0.014425 ND ND M Outer membrane
G41 GyrB ↓↓↓ − 0.056566 0.044323 0.031419 ND ND L Cytoplasm
G42 NuoG ↓↓↓↓ 0.041560 0.015792 0.006317 0.003104 ND C Unknown
G43 PflB ↑↑↓↓ 0.023916 0.166535 0.357236 0.213656 0.156831 C Cytoplasm
G44 FrdA ↑↑→→ 0.024844 0.153955 0.268106 0.210036 0.216294 C Periplasmic space
G45 CysK ↗↘↓↓ 0.532310 0.579598 0.505064 0.396238 0.319571 E Cytoplasm
G46 RplI ↓↓↘↘ 0.948121 0.723898 0.531108 0.494982 0.456412 J Cytoplasm
G48 DksA ↓↓↗↗ 0.405237 0.322842 0.259510 0.279721 0.301116 T Cytoplasm
G49 AceF ↓↓↓↓ 0.241263 0.190662 0.142464 0.069324 ND C Cytoplasmic membrane
G50 KatG ↑↑↓↑ 0.017953 0.042435 0.113385 0.091106 0.147822 P Cytoplasm
G51 KatG ↑↑↑↑ 0.003988 0.119471 0.188529 0.229915 0.324765 P Cytoplasm
G52 KatG ↑↑↑→ 0.011194 0.078571 0.112013 0.187740 0.188632 P Cytoplasm
G53 KatG ↑↑↗→ 0.034072 0.171998 0.236931 0.275466 0.283478 P Cytoplasm
G54 FucO ↑↑↑↑ 0.041224 0.078824 0.142970 0.279402 0.347836 C Cytoplasm
G55 OmpA ↑↑↘→ 0.312340 0.477371 0.670019 0.582806 0.593284 M Outer membrane
G56 PurC ↓→↑↑ 0.093432 0.077450 0.077493 0.188113 0.227420 – Unknown
*1Ratio A is defined to represent the ratio of the relative abundance of one stage to its previous one, and Ratio B is
defined to represent the ratio of the relative abundance of one stage to its next one. Then ↑ indicates Ratio A >1.2, ↓
indicates Ratio B >1.2,↗ indicates Ratio A between 1.05 and 1.2,↘ indicates Ratio B between 1.05 and 1.2, and→ in-
dicates Ratio A and Ratio B <1.05. *2The relative abundance of protein spot is represented by using the relative volume
calculated. ND indicates that the protein spot was not detected in this stage. *3Each letter represents a particular func-
tional category. These single letter codes can be decoded at the COG service (http://www.ncbi.nlm.nih.gov/COG/).
Discussion
Comparative genomics studies have shown that S.
ﬂexneri is closely related to E. coli and they might
belong to the same genus based on DNA homology
(8 , 9 ). Given the physiology research of S. ﬂexneri is
still limited, the features and functions of these pro-
teins are mainly deduced from the information of ho-
mologous proteins in E. coli.
Carbon metabolism
From exponential growth to stationary phase, the
available carbon resources in culture were gradually
depleted. Carbon-starved bacterial cells were found
to increase their synthesis of glycolysis enzymes, with
a reduced production of tricarboxylic acid (TCA)
cycle enzymes (10 ). The reaction catalyzed by pyru-
vate dehydrogenase is the gateway to the TCA cycle,
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producing acetyl-CoA for the first reaction. The E1
(AceE, Spot G25) and E2 (AceF, Spot G49) compo-
nents of this multienzyme complex were expressed de-
creasingly during the growth phase transition. The 2-
oxoglutarate dehydrogenase is one of the key enzymes
in the TCA cycle. The expression of E1 (SucA, Spot
G35) and E2 (SucB, Spot G28) components of this
multienzyme complex were also synchronally reduced
in our experiments.
The expression of pyruvate-formate lyase (PflB,
Spot G43), an enzyme critical in mixed acid fermen-
tation, was significantly increased from Stages I to
III, then decreased from Stages IV to V. Another pu-
tative pyruvate-formate lyase (YfiD, Spot G02) was
expressed increasingly from Stages I to III, and then
the amount of this protein maintained, just like the
phenomenon observed in E. coli (11 ). These results
supported the study that bacterial cells would convert
their aerobic metabolism into anaerobic fermentation
upon the stationary phase (12 ).
Respiratory electron acceptor
The fumarate reductase converts fumarate to succi-
nate, acting as the key enzyme in fumarate respira-
tion. We found that the expressions of fumarate re-
ductase subunits A (FrdA, Spot G44) and B (FrdB,
Spot G08) were induced during the growth phase
transition. This indicated that cells of S. ﬂexneri
controlled their aerobic respiration and turned to use
fumarate respiration to generate a proton gradient.
According to a previous report, fumarate is man-
ufactured from C4-dicarboxylates and related com-
pounds in Luria-Bertani (LB) medium, including ox-
aloacetate, malate, and aspartate (13 ). In our exper-
iments, aspartase (AspA, Spot G06) and periplasmic
asparaginase II (AnsB, Spot G04) were greatly in-
duced. Therefore, AspA might have a role together
with AnsB in the utilization of exogenous asparagine
and the generation of fumarate. Accordingly, we can
say, if aspartate (asparagine) was enough, the sta-
tionary accumulation of succinate might largely re-
sult from conversion of aspartate (asparagine) to fu-
marate via aspartase (and asparaginase), followed by
reduction via fumarate reductase in fumarate respira-
tion, although succinate could be produced through
reductive branch of the TCA cycle pathway, which is
the main pathway for succinate production in Saccha-
romyces cerevisiae during anaerobic glucose fermen-
tation (14 ).
Oxidative defense machinery
Oxidation damage may be the Achilles’s heel of
stationary-phase bacterial cells, since many reported
genes induced by stasis are related to the oxida-
tive defense machinery (4 , 15 ). In our experiments,
the expression of Mn-cofactored superoxide dismutase
(SodA, Spot G19), which converts superoxide anions
into molecular oxygen and hydrogen peroxide, was re-
pressed. However, the bifunctional hydroperoxidase I
(KatG, Spots G50–53), having both catalase and per-
oxidase activity, was induced greatly. This indicated
that there were two different systems in the response
of S. ﬂexneri to the oxidation damage caused by re-
active oxygen species, and KatG might play an im-
portant role in the stationary-phase oxidative defense
machinery.
Interestingly, the KatG protein was identified in
the present study as four separate spots (G50–53)
with the same molecular weight but different isoelec-
tric point values. This indicated that there might be
two different modifications after translation for the
two different functions of this enzyme, and there are
two forms (reduced form and oxidated form) for each.
Translation-related proteins
The expressions of some ribosomal proteins were
reduced during this transition, such as 50S ribo-
somal subunit protein L9 (RplI, Spot G46), 30S
ribosomal subunit protein S6 (RpsF, Spot G34),
and 30S ribosomal subunit protein S1 (RpsA, Spot
G14). In the present study, we also identified some
tRNA synthetases (or subunits), including aspartate
tRNA synthetase (AspS, Spot G17), alanyl-tRNA
synthetase (AlaS, Spot G18), asparagine tRNA syn-
thetase (AsnS, Spot G20), serine tRNA synthetase
(SerS, Spot G26), and glutamate tRNA synthetase
catalytic subunit (GltX, Spot G29). The expression
patterns of these proteins showed a trend of decreas-
ing, although some fluctuating expressions existed.
According to a previous report, the reduced pro-
duction of proteins involved in translation might re-
sult from sigma factor competition (σS/σ70) for RNA
polymerase binding (16 ).
Outer membrane proteins
The protein with the most significant change in ex-
pression level is a putative outer membrane protein
Geno. Prot. Bioinfo. Vol. 5 No. 2 2007 117
Growth Phase-Dependent Proteins of S. ﬂexneri
YciD (OmpW, Spot G01), which could be seen as the
hallmark of the stationary phase. A previous study
showed that the protein is a receptor for Colicin S4
(17 ), but our data obviously suggested another role
of this protein related to the growth of S. ﬂexneri.
Then, a YciD null mutant strain was constructed
by using the λ-phase Red recombination system (18 ).
The mutant strain grew faster than wild-type strains
in the liquid culture, and reached a higher final cul-
ture density. The colony diameter of the mutant
strain was also bigger than wild-type strains. These
primary results supported our hypothesis that the
YciD protein controlled the growth of this pathogen.
Furthermore, due to the polar localization of YciD
(19 ), it might regulate the growth by changing the
permeability of outer membrane.
Another outer membrane protein OmpA (Spot
G55), which is one of the most abundant proteins in
the outer membrane of E. coli, showed a trend of in-
creasing in expression level. It was believed to form a
nonspecific diffusion channel, allowing various small
solutes to cross the outer membrane (20 ). In addi-
tion, the expression of protein OmpX (Spot G33) was
reduced during the growth phase transition. The bi-
ological function of OmpX is still not clear, although
the study on this protein has obtained some informa-
tion recently (21 ). Interestingly, the targeting pro-
cesses of OmpA and OmpX to the Sec-translocase for
transport across the inner membrane were both SecB-
dependent (22 ).
Other proteins
The expression of the universal stress protein YnaF
(UspF, Spot G03) was dramatically induced during
the growth phase transition. UspF has an adenine
nucleotide-binding domain, and was found to be up-
regulated under glucose limited conditions in a previ-
ous proteomic research of E. coli (23 ). Further anal-
yses of this protein are now being processed.
Glycerophosphoryl diester phosphodiesterase
(GlpQ, Spot G13) could hydrolyze deacylated phos-
pholipids to an alcohol plus Glycerol-3-P that is sub-
sequently transported into the cell and utilized as
carbon sources. The expression of this enzyme was
increasingly induced in our experiments. Thus, this
protein might be involved in the stationary autophagy
(dwarfing phenomenon), an important survival mech-
anism of bacteria (4 ).
The global regulator FNR
Many of the identified proteins (10/46) were un-
der the control of the global transcriptional regulator
FNR. Among these proteins, AceEF, NuoG, OmpX,
SodA, SucAB, and YfiD were negatively regulated by
FNR (24 , 25 ) and their expressions were reduced in
our work; AnsB, AspA, FrdAB, and KatG were pos-
itively regulated by FNR (24 , 25 ) and their expres-
sions were increased in our work. This is in agree-
ment with the function of FNR. Therefore, the global
transcriptional regulator FNR should play a key role
in the growth phase transition.
Previous studies reported that the activity of FNR
was regulated by oxygen. It would be active only dur-
ing anaerobic growth and become inactivated even at
very low O2-tensions (1 µM) (26 ). Interestingly, our
experiments were carried out at aerobic conditions.
The expression changes of those proteins might be due
to the decreasing amount of dissolved oxygen from ex-
ponential growth to stationary phase. Another possi-
ble explanation is that there is another defense mech-
anism to activate FNR (or another similar regulator?)
for reducing the redox potential. This defense system
would function at microaerobic stress conditions to
protect the cell against potentially oxidative damages.
Benefiting from the high-resolution 2-D PAGE
method, the majority of our results were coinci-
dent with those physiology phenomena reported pre-
viously. This global expression profiling research
has revealed previously unrecognized relationships be-
tween different proteins and pathways in the life of S.
ﬂexneri 2a 2457T. These data provide a better under-
standing of the question that how protein production
is regulated during the growth of this pathogen.
Materials and Methods
Preparation of whole-cell protein ex-
tract
A virulent S. ﬂexneri serotype 2a strain 2457T was
grown aerobically in 200 mL LB medium at 37◦C.
Cells were harvested at five time points from the ex-
ponential phase at an optical density OD600nm of 0.6
till the bacteria grew into the stationary phase (rep-
resented as Stages I–V). The preparation of whole-
cell protein extract was performed as described pre-
viously (27 ). The protein concentration of samples
was measured by using the PlusOne 2-D Quant Kit
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(Amersham Biosciences, Piscataway, USA), and 0.8
mg aliquots were stored at −80◦C.
2-D PAGE
Isoelectric focusing (IEF) was performed by using im-
mobilized pH gradient (IPG) strips (18 cm; Amer-
sham Biosciences) at 20◦C for 60,000 V·h. After IEF,
each strip was equilibrated as described previously
(28 ). For the second dimension, vertical slab sodium
dodecyl sulfate (SDS)-PAGE (12.5%) was performed
for about 4.5 h at 30 mA/gel by using a Bio-Rad Pro-
tean II Xi apparatus (Bio-Rad, Hercules, USA).
Image analysis was processed by ImageMaster 2D
Platinum software (Amersham Biosciences), and the
images of five stages (I–V) were compared. The rel-
ative volume of each spot was determined from the
spot intensities in pixel units and normalized to the
sum of the intensities of all the spots on the gel.
In-gel protein digestion and MALDI-
TOF MS
The Coomassie-stained protein spots of interest
were cut out, and in-gel protein digestion was per-
formed as described previously (28 ). Peptides
from digested proteins were resolubilized in 2 µL
of 0.5% triflouroacetic acid (TFA). Peptide mass
fingerprinting measurements were performed on a
Bruker ReflexTM III MALDI-TOF mass spectrome-
ter (Bruker, Bremen, Germany) working in reflectron
mode with 20 kV of accelerating voltage and 23 kV of
reflecting voltage. A saturated solution of α-cyano-
4-hydroxycinnamic acid in 50% acetonitrile and 0.1%
TFA was used for the matrix. A total of 2 µL of
the matrix solution and sample solution were mixed
in a 1:1 (v/v) ratio and applied onto the Score 384
target well. The mass accuracy for peptide mass
fingerprinting analysis was 0.1–0.2 Da with external
calibration, and internal calibration was carried out
by using enzyme autolysis peaks with the resolution
of 12,000.
Protein identification
Database searches were performed by using the Mas-
cot software (Matrix Science Ltd., London, UK)
licensed in-house for the database of S. ﬂexneri
2a 2457T (4,668 sequences) and checked again by
using Mascot with free access on the Internet
(www.matrixscience.com). Monoisotopic masses were
used to search the databases, allowing a peptide mass
error of 0.3 Da and one partial cleavage. Oxida-
tion of methionine and carbamidomethyl modification
of cysteine were considered. For unambiguous iden-
tification of proteins, more than five peptides must be
matched, and the sequence coverage must be greater
than 15%.
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